Meyka Pro banner
McKesson Corporation

McKesson Corporation (MCK) Stock Overview

Explore McKesson Corporation’s financial performance, market position, analyst ratings, and future outlook.

MCK●NYSE
HealthcareMedical - Distribution
$994.58
$13.70(1.40%)
U.S. Market opens in 45h 7m

McKesson Corporation (MCK)

Meyka AI Score

Z

Key Financials

Market Cap116.1B
P/E Ratio26.43
EPS (TTM)$40.82
ROE-1.94%
Fundamental Analysis

AI Price Forecasts

1 Month$1070.07
3 Months$972.42
1 Year Target$917.68

MCK Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of McKesson Corporation (NYSE: MCK) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, McKesson Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MCK on the NYSE shows an RSI of 60.83, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $917.68 for the NYSE listing.

Key metrics behind McKesson Corporation's NYSE-traded stock include a P/E ratio of 26.43 and a market capitalization of 116.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MCK on the NYSE.

Price Performance (NYSE: MCK)

1-Day Change
1.48%
5-Day Change
-1.48%
1-Month Change
16.58%
3-Month Change
15.004%
6-Month Change
22.10%
Year-to-Date (YTD) Change
21.34%
1-Year Change
20.57%
3-Year Change
121.47%
5-Year Change
378.36%
All-Time (Max) Change
5932.55%

Contact Information

972 446 4800
6555 State Highway 161, Irving, TX, 75039

Company Facts

423,000 Employees
IPO DateNov 10, 1994
CountryUS
Actively Trading

Frequently Asked Questions